Page last updated: 2024-08-26

10-hydroxycamptothecin and paclitaxel

10-hydroxycamptothecin has been researched along with paclitaxel in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, XL; Cheng, G; Lin, HW; Tang, HF; Wen, AD; Wu, J; Zhang, SY1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Li, L; Li, N; Wang, J; Yang, X1
Jie, J; Liu, Z; Tian, B; Yang, Y; Zhang, X; Zhou, M1
Bai, J; Bian, Z; Chen, F; Fu, S; Guan, R; Jin, Y; Quan, C; Sun, W; Wu, J; Xu, L; Yu, Y1

Other Studies

5 other study(ies) available for 10-hydroxycamptothecin and paclitaxel

ArticleYear
Cytotoxic asterosaponins capable of promoting polymerization of tubulin from the starfish Culcita novaeguineae.
    Journal of natural products, 2009, Feb-27, Volume: 72, Issue:2

    Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Saponins; Starfish; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2009
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Novel nanogels as drug delivery systems for poorly soluble anticancer drugs.
    Colloids and surfaces. B, Biointerfaces, 2011, Apr-01, Volume: 83, Issue:2

    Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Screening Assays, Antitumor; Gels; Humans; Micelles; Molecular Structure; Nanostructures; Paclitaxel; Solubility

2011
Carrier-free functionalized multidrug nanorods for synergistic cancer therapy.
    Biomaterials, 2013, Volume: 34, Issue:35

    Topics: Animals; Camptothecin; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Carriers; Drug Synergism; Drug Therapy, Combination; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; KB Cells; MCF-7 Cells; Methotrexate; Mice; Mice, Inbred BALB C; Nanoparticles; Nanotubes; Neoplasms; Paclitaxel

2013
RPL13A as a reference gene for normalizing mRNA transcription of ovarian cancer cells with paclitaxel and 10-hydroxycamptothecin treatments.
    Molecular medicine reports, 2015, Volume: 11, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Computational Biology; Female; Gene Expression Profiling; Humans; Ovarian Neoplasms; Paclitaxel; Ribosomal Proteins; RNA Stability; RNA, Messenger; Transcription, Genetic

2015